Announcements Trials

Browse Landscape

Phase

Phase 2 94 Phase 1 57 Phase 1/2 50 Phase 3 9 Phase EARLY_PHASE1 4 Phase 2/3 2 Phase NA 1 Phase 4 1

Status

Recruiting 4 Completed 4 Unknown 2 Active not recruiting 2 Withdrawn 1 Terminated 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Radiosurgery 28 Magnetic Resonance Spectroscopy 25 Blood Specimen Collection 20 Radiotherapy 19 Surveys and Questionnaires 18 Exercise 16 Early Intervention, Educational 16 Methods 15 Cyclophosphamide 15 Surgical Procedures, Operative 14 Standard of Care 14 Radiotherapy, Intensity-Modulated 14 Biopsy 13 Acupuncture Therapy 12 Interviews as Topic 11 Cisplatin 11 Filgrastim 10 Educational Status 10 Radiofrequency Ablation 9 Magnetic Resonance Imaging 9 Fluorodeoxyglucose F18 9 fludarabine phosphate 8 Radiation 8 Gemcitabine 8 X-Rays 7 Sorafenib 7 Practice Guidelines as Topic 7 Granulocyte Colony-Stimulating Factor 7 Colonoscopy 7 Capecitabine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Terminated × Nivolumab × Clear all

NCT04801966 2023-05-10

TAILOR

Peter MacCallum Cancer Centre, Australia

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡